Aspire Biopharma Provides Q3 2025 Business Update
Go back to Aspire Biopharma Provides Q3 2025 Business Update| (NASDAQ: ASBP) | Delayed: 7.79 +0.06 (0.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.73 | 52 Week High | $ | |||
| Open | $7.92 | 52 Week Low | $ | |||
| Day High | $8.00 | P/E | N/A | |||
| Day Low | $7.33 | EPS | $ | |||
| Volume | 83,371 | |||||

